HCPCS code C9066 — Sacituzumab govitecan-hziy.
Status: Deleted.
Effective Jan 1, 2021.
Source: CMS HCPCS Level II.
C9066
DeletedSacituzumab govitecan-hziy
Injection, sacituzumab govitecan-hziy, 2.5 mg
Code C9066 has been deleted from the HCPCS Level II set.
Termination date: Dec 31, 2020. Claims with a date of service on or after this day will be denied under this code.
No successor code has been identified. Consult the CMS HCPCS Update Summary for guidance.
Category:
Outpatient PPS
Section:
C-codes: Outpatient PPS
Effective:
Jan 1, 2021
Terminated:
Dec 31, 2020
Code type:
alphanumeric
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.